Every SEC Form 3/4/5 on record for this filer (CIK 1758842) — 4 issuers, 16 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Chief Legal Officer | 2024-03-05 → 2025-09-09 | 5 | −$55,239 |
| FRTX | Fresh Tracks Therapeutics, Inc. | Gen Counsel, CCO, & Secretary · lapsed | 2023-01-26 → 2023-10-04 | 2 | — |
| BBI | Brickell Biotech, Inc. | General Counsel and CCO · lapsed | 2019-09-09 → 2022-05-09 | 10 | $52,181 |
| ECYT | ENDOCYTE INC | General Counsel · lapsed | 2018-11-15 → 2018-12-21 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| TEVA | 2025-09-05 | Buy | 1,113 | $18.86 | $20,991 | 13,027 |
| TEVA | 2025-03-05 | Sell | 1,677 | $15.91 | $26,681 | 11,914 |
| TEVA | 2025-03-04 | Sell | 3,150 | $15.73 | $49,550 | 13,591 |
| BBI | 2021-07-23 | Buy | 18,124 | $0.67 | $12,143 | 128,879 |
| BBI | 2021-05-17 | Buy | 18,622 | $0.80 | $14,898 | 110,755 |
| BBI | 2021-05-17 | Buy | 7,980 | $0.80 | $6,384 | 13,980 |
1 of 4 issuers are covered and open a security page; the rest are on file here only.
